Xiaoge Sun
Senior author of a 2026 study showing that the recurrent PIK3CA-E545K mutation drives cervical cancer growth and invasion through AKT/mTOR signalling
Department of Radiation Oncology · Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
Xiaoge Sun is the corresponding author of a 2026 study that sequenced paired tumor/non-tumor tissue from 61 cervical cancer patients and found PIK3CA among the most frequently mutated genes. In cell and mouse xenograft models, the mutant boosted tumor cell proliferation and invasiveness while suppressing apoptosis, acting through sustained AKT/mTOR pathway activation — supporting PI3K/AKT/mTOR-axis inhibitors as a rational therapeutic strategy for this cervical cancer subgroup.
Milestones in the Atlas
A selection, not a full bibliography: only papers that meet the Atlas inclusion criteria.
| Year | Evidence | Study |
|---|---|---|
| 2026 | M | Recurrent PIK3CA-E545K mutation promotes cervical cancer growth and invasion via AKT/mTOR signaling. HUANG2026 Corresponding author on genomic and functional work showing the PIK3CA-E545K mutation drives cervical cancer growth and invasion through sustained AKT/mTOR pathway activation. |
Co-authors in the Atlas 1
People with a profile here who share at least one study with Xiaoge Sun.
ShowHide
- Congxiu Huang Radiation oncology researcher in Hohhot and first author of a study linking the PIK3CA E545K mutation to faster growth and invasion of cervical cancer through AKT/mTOR signalling
Every researcher with a profile →
Thank you. That helps us know which pages have been read by someone who knows the work.
Thank you. We will check it and correct the page.
Thank you. Your answer was counted anonymously.